Propranolol for Performance Anxiety: Dose and What to Expect

You know the physical symptoms. Heart pounding visibly. Hands trembling. Voice wavering on the first sentence. Visible flushing rising up your neck before you have said a word.

Performance anxiety produces those symptoms through a predictable physiological mechanism: the sympathetic nervous system releasing adrenaline, adrenaline binding to beta-adrenergic receptors throughout the body, and those receptors translating the emotional signal into physical crisis. The mechanism is involuntary. The symptoms are often the most disabling part.

Propranolol interrupts that chain. It blocks the beta-adrenergic receptors before adrenaline can reach them. The result is a heart that does not race uncontrollably, hands that stay steadier, and a voice that does not betray the physiological state underneath.

What This Page Covers

• What propranolol actually does and does not do for performance anxiety
• The clinical evidence for this specific use
• Standard dose and timing
• Who should not take it and why
• The important distinction between performance anxiety and social anxiety disorder
• How propranolol fits into a broader anxiety management approach

What Propranolol Does for Performance Anxiety

Propranolol is a non-selective beta-adrenergic receptor blocker. Its primary clinical applications are cardiovascular: it treats high blood pressure, certain arrhythmias, and angina. It is also used off-label for performance anxiety, which is a subset of situational anxiety presenting with tachycardia, sweating, and flushing that occurs secondary to increased activation of the sympathetic nervous system.

For performance situations specifically, propranolol works by preventing adrenaline and norepinephrine from activating beta-1 receptors in the heart and beta-2 receptors in the peripheral tissues. The effect is precise and practical:

• Heart rate does not escalate uncontrollably
• Visible hand tremor is reduced
• Sweating decreases
• Voice steadying: the physical mechanism of voice wavering under adrenaline is interrupted
• Blushing is reduced through peripheral vascular effects

What propranolol does NOT do: it does not reduce the subjective experience of anxiety, negative thoughts about performance, fear of judgment, or the cognitive component of performance fear. It addresses the body’s output, not the brain’s interpretation. Many performers find this distinction useful: the physical symptoms of anxiety are often what they most need to control, and eliminating them reduces the feedback loop in which visible anxiety makes the cognitive anxiety worse.

The Evidence for Performance Anxiety Specifically

Propranolol is not FDA-approved for anxiety in the United States. In the UK, it is licensed for anxiety treatment. Off-label prescribing for performance anxiety has been common in clinical practice for decades, particularly among musicians, public speakers, surgeons, and students taking high-stakes examinations.

The evidence base is modest but specifically targets performance contexts. Performance quality has been reported to improve and the degree of pre-performance anxiety has been determined to decrease upon treatment with propranolol. A review of studies found propranolol consistently reduces the physical performance barriers without producing the sedation or cognitive dulling associated with benzodiazepines.

An important caveat: the quality of clinical trial evidence for propranolol in anxiety disorders broadly is low, with many early studies having small sample sizes and design limitations. A 2024 systematic review noted that robust RCT evidence is limited. However, the real-world clinical experience and the mechanistic logic are both strong for situational performance anxiety specifically: the physical symptoms propranolol blocks are the exact symptoms that most disrupt performance, and the effect is well-understood pharmacologically.

The evidence is most robust for the performance-specific, situational use case. For chronic generalized anxiety or social anxiety disorder, propranolol is a much weaker choice.

Standard Dose and Timing

For performance or situational anxiety, the standard approach is immediate-release propranolol at a dose of 10 to 40 mg taken 30 to 60 minutes before the anxiety-inducing event.

For a first use, most prescribers recommend starting at the lower end: 10 or 20 mg. This allows you to assess your individual response before a high-stakes event. Propranolol’s effects on heart rate can vary by person, and some individuals are more sensitive than others.

Practical considerations:

• Take it on a consistent schedule relative to the event: 45 to 60 minutes before is typically optimal
• Effects last approximately 3 to 6 hours, which covers most performance situations
• Do not test it for the first time immediately before a high-stakes event: test it in a lower-stakes situation first to know how your body responds
• Propranolol can be taken with or without food

There is no officially established maximum dose for performance anxiety given its off-label status. Your prescriber determines the appropriate dose based on your medical history, current medications, and clinical response.

Who Should Not Take Propranolol

Propranolol’s beta-2 receptor blockade in the lungs and elsewhere creates meaningful contraindications:

Asthma and COPD: Beta-2 blockade causes bronchoconstriction. In people with reactive airway disease, propranolol can trigger severe bronchospasm. Propranolol is contraindicated in patients with asthma, COPD, or emphysema because blocking beta-2 receptors causes vasoconstriction of smooth muscle, worsening respiratory function. If you have any lung condition, discuss this specifically with your prescriber before taking propranolol.

Bradycardia: Because propranolol slows the heart rate, it is contraindicated in people with a resting heart rate below approximately 60 beats per minute (bradycardia) or certain heart blocks.

Heart failure: Propranolol is contraindicated in decompensated heart failure.

Diabetes: Propranolol can mask the symptoms of hypoglycemia, including tachycardia and sweating, which are the body’s natural warning signs of low blood sugar. Prescribers should exercise extreme caution when prescribing propranolol to patients with diabetes for exactly this reason.

Drug interactions: Propranolol interacts with several classes of medications including calcium channel blockers, certain antiarrhythmics, NSAIDs, antidepressants, and thyroid medications. A complete medication review before starting is essential.

Performance Anxiety vs. Social Anxiety Disorder

This distinction matters clinically and determines whether propranolol is the right tool.

Performance anxiety is situational and circumscribed. It is triggered by specific high-stakes performance contexts: public speaking, musical performance, a surgical procedure, an important examination. Between those situations, the person functions without significant anxiety. The physical symptoms are the primary barrier.

Social anxiety disorder (SAD) is a generalized condition involving persistent fear of social situations, negative evaluation, and social avoidance across a broad range of contexts. It is not limited to performance situations and does not resolve between events.

Propranolol is appropriate for performance anxiety. It is not a standalone treatment for social anxiety disorder. A review of clinical evidence found that the evidence base for propranolol in performance-specific situations is stronger than for chronic anxiety disorders, and that the quality of evidence for routine use in anxiety disorders broadly is insufficient to support widespread use. SAD requires SSRIs and typically cognitive behavioral therapy; propranolol alone addresses only the surface physical symptoms and does not treat the underlying disorder.

If you are unsure which category you fall into, a clinical evaluation is the right next step before reaching for propranolol.

Propranolol Within a Broader Approach

For people whose performance anxiety is a component of a larger anxiety picture, including chronic worry, heightened baseline anxiety between performances, or co-occurring depression, propranolol for the acute performance situation can be one tool among several.

Daily medication for chronic anxiety and depression addresses the baseline from which performance anxiety escalates. Someone whose baseline anxiety is well-managed, whose sleep is less disrupted, and whose amygdala reactivity has been reduced through SSRI treatment may find that performance situations are more manageable with or without propranolol.

For people managing both daily anxiety treatment and situational performance anxiety, coordination between the two approaches, knowing which medications are safe to combine and what each is doing, is part of good clinical management.

About SiggyMD

SiggyMD provides clinician-supervised medication management for anxiety and depression. For patients whose chronic anxiety includes a performance or situational component, addressing the baseline anxiety through daily medication changes the terrain on which performance anxiety develops.

The daily check-in model means your prescriber can see whether your baseline anxiety is trending in a direction that would affect how you respond to upcoming high-stakes situations, not just at the next quarterly appointment.

“Propranolol for a specific performance event is a straightforward and well-understood tool when the clinical picture is right,” says Daniel Montville, MD, Psychiatrist at SiggyMD. “What I often see is that the performance anxiety is actually a peak expression of a higher baseline anxiety that never fully came down. Treating the baseline with appropriate daily medication changes how much propranolol, or any acute intervention, is doing to compensate for an undertreated underlying condition.”

The anonymous intake at SiggyMD requires no name, email, or account to begin. A licensed prescriber reviews every treatment plan.

For a broader overview of propranolol use in anxiety, read our post on propranolol for anxiety. For information on how beta-blockers compare with SSRIs for anxiety, see beta-blockers vs. SSRIs for anxiety.

Start your anonymous intake with SiggyMD to talk with a prescriber about anxiety, medication management, and what treatment approach fits your situation.

What Members Are Saying

JN

J.N., 34

Public Speaker / Performance Anxiety

“I gave presentations weekly and dreaded each one because my heart would race so visibly that I would lose the thread. My prescriber prescribed propranolol 20 mg for one hour before. The heart racing stopped. That is the only word for it. My baseline fear didn’t disappear, but I stopped being distracted by the physical spectacle of it, and that changed everything.”

PK

P.K., 42

Musician

“I had avoided certain repertoire for years because my hands would shake in high-register passages under pressure. Propranolol was the difference between being able to perform it and not. But I should say: I also started treating my general anxiety with an SSRI. The propranolol handles the performance situation. The SSRI handles the other eighteen hours of the day.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

If you are in crisis or experiencing thoughts of self-harm, call or text 988. If there is immediate danger, call 911.

Sources

1. StatPearls. Propranolol. NCBI Bookshelf. Updated 2024.

2. Szeleszczuk L, Fraczkowski D. Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder. International Journal of Molecular Sciences. 2022;23(17):10099.

3. Archer C, et al. Beta-Blockers for the Treatment of Anxiety Disorders: A Systematic Review and Meta-Analysis. Journal of Affective Disorders. 2025;368:90-99.

4. GoodRx. What to Know About Using Propranolol for Performance Anxiety. Accessed June 2026.

5. National Institute of Mental Health. Anxiety Disorders. NIMH. Accessed June 2026.